Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2014 07:00 ET | Source: Akers Biosciences Inc.

Akers Biosciences Announces Its Financial Results for Third Quarter 2014

THOROFARE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing...
November 10, 2014 07:00 ET | Source: Akers Biosciences Inc.

Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results

THOROFARE, N.J., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
October 23, 2014 08:17 ET | Source: Akers Biosciences Inc.

Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China

THOROFARE, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
September 16, 2014 12:45 ET | Source: Akers Biosciences Inc.

Akers Biosciences Features on Global Broadcast & Online Media

THOROFARE, N.J., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces...
September 09, 2014 13:42 ET | Source: Akers Biosciences Inc.

Akers Biosciences Presenting at US Investor Conferences

Executive Chairman Raymond F. Akers Jr., Ph.D, to present at: Rodman & Renshaw 16th Annual Global Investment Conference; and Aegis Capital Corporation 2014 Healthcare & Technology...
September 09, 2014 07:30 ET | Source: Akers Biosciences Inc.

Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test

THOROFARE, N.J., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
August 12, 2014 07:00 ET | Source: Akers Biosciences Inc.

Akers Biosciences Reports Its Second Quarter Financial Results

Sales of flagship PIFA Heparin/PF4 products increasing Conference call scheduled for 10:15 a.m. ET today THOROFARE, N.J., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER)...
August 11, 2014 12:17 ET | Source: Akers Biosciences Inc.

Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results

THOROFARE, N.J., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
August 05, 2014 02:00 ET | Source: Akers Biosciences Inc.

Akers Appoints New Vice President of International Sales and Marketing to Build International Business

THOROFARE, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
July 28, 2014 02:00 ET | Source: Akers Biosciences Inc.

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses

THOROFARE, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right